PTSD comorbidities in patients undergoing ECT for major depressive disorder: a national study across the United States

Código QR

PTSD comorbidities in patients undergoing ECT for major depressive disorder: a national study across the United States

Guardado en:

Detalles Bibliográficos
Autores principales:	Nagy Youssef, Rikinkumar Patel
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/7bd3f42f0770455c90616e2d769c203c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Psychiatric comorbidities in patients with major depressive disorder
por: Thaipisuttikul P, et al.
Publicado: (2014)

Baseline symptom profile does not predict early response to electroconvulsive therapy (ECT) in major depressive disorder (MDD)
por: Bijan Zarrabi, et al.
Publicado: (2021)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue T, et al.
Publicado: (2020)

Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
por: Demir S, et al.
Publicado: (2015)

Repetitive transcranial magnetic stimulation for major depressive disorder comorbid with huntington’s disease: a case report
por: Clémence Noiseux, et al.
Publicado: (2021)

Comorbid personality disorders among patients with depression
por: Wongpakaran N, et al.
Publicado: (2015)

Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder
por: Sandra Torres Galván, et al.
Publicado: (2021)

Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population
por: Kawamura S,&nbsp;Maesawa C,&nbsp;Nakamura K,&nbsp;Nakayama K,&nbsp;Morita M,&nbsp;Hiruma Y,&nbsp;Yoshida T,&nbsp;Sakai A,&nbsp;Masuda T
Publicado: (2011)

Treatment of refractory obsessive-compulsive disorder with comorbid major depression with sequential multi-locus transcranial magnetic stimulation
por: Reza Tadayonnejad, et al.
Publicado: (2021)

Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
por: Matsui K, et al.
Publicado: (2017)

The influence of comorbid personality disorders on recovery from depression
por: Wongpakaran T, et al.
Publicado: (2015)

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study
por: Fontani V, et al.
Publicado: (2011)

A review of ketamine’s role in ECT and non-ECT settings
por: Jankauskas V, et al.
Publicado: (2018)

Transient neural oscillations reveal new biomarkers for therapeutic transcranial magnetic stimulation for comorbid MDD and PTSD
por: Alexander Morris, et al.
Publicado: (2021)

Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009)

Evaluation of the risk factors of depressive disorders comorbid with obstructive sleep apnea
por: Cai LQ, et al.
Publicado: (2017)

TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic
por: Michael A. Norred, et al.
Publicado: (2021)

Stress disorder and PTSD after burn injuries: a prospective study of predictors of PTSD at Sina Burn Center, Iran
por: Sadeghi-Bazargani H, et al.
Publicado: (2011)

Depression, anxiety, PTSD, and OCD after stillbirth: a systematic review
por: Cèline Lossius Westby, et al.
Publicado: (2021)

IMPACT OF CYTOKINES UPON COMORBID STATES OF CORONARY ARTERY DISEASE AND AFFECTIVE DISORDERS ASSOCIATED WITH DEPRESSION AND ANXIETY
por: S. N. Kozlova, et al.
Publicado: (2014)

Predictors of Major Depressive Disorder in Older People
por: Susana Sousa, et al.
Publicado: (2021)

Comorbidities in Obsessive-Compulsive Disorder Across the Lifespan: A Systematic Review and Meta-Analysis
por: Eesha Sharma, et al.
Publicado: (2021)

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
por: Zvěřová M, et al.
Publicado: (2019)

Plasma proteomic data in bipolar II disorders and major depressive disorders
por: Hyunju Lee, et al.
Publicado: (2021)

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder
por: Tu Z, et al.
Publicado: (2018)

The role of neuroinflammation and neurovascular dysfunction in major depressive disorder
por: Jeon SW, et al.
Publicado: (2018)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Mazen K Ali, et al.
Publicado: (2011)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: J Craig Nelson, et al.
Publicado: (2008)

Mitochondrial dysfunction, oxidative stress, and major depressive disorder
por: Tobe EH
Publicado: (2013)

Levomilnacipran for the treatment of major depressive disorder: a review
por: Asnis GA, et al.
Publicado: (2015)

Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
por: F Kheirkhah, et al.
Publicado: (2010)

Epigenome-wide meta-analysis of PTSD across 10 military and civilian cohorts identifies methylation changes in AHRR
por: Alicia K. Smith, et al.
Publicado: (2020)

The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
por: Yinghua Zhong, et al.
Publicado: (2021)

PTSD research quarterly
Publicado: (1990)

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
por: Bo Q, et al.
Publicado: (2019)

Associations of serum cystatin C with depressive symptoms and suicidal ideation in major depressive disorder
por: Ting Sun, et al.
Publicado: (2021)

Major depressive disorder: mechanism-based prescribing for personalized medicine
por: Saltiel PF, et al.
Publicado: (2015)

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
por: Yang X, et al.
Publicado: (2015)

Elevated peripheral blood glutamate levels in major depressive disorder
por: Inoshita M, et al.
Publicado: (2018)

Sex differences in gut microbiota in patients with major depressive disorder
por: Chen JJ, et al.
Publicado: (2018)